Understanding OUR Cytokine-Based Immunotherapy Candidates Our Dedication extends to advancing a robust portfolio of programs geared toward expanding the horizons of cytokine-based immunotherapy, especially for cancers where therapy choices remain limited. Use the links below to learn much more about our portfolio of cytokine-based immunotherapy candidates. Discover Our Pipeline https://financefeeds.com/cme-group-to-launch-brokertec-clob-for-cash-us-treasuries-in-q3-2025/